Clinical Trials Browser

Esophageal Neoplasms × rilotumumab × Gastrointestinal × Clear all

NCT01443065 2020-11-17

MEGA

Phase 2 Completed

Gastrointestinal

Adenocarcinoma, Esophageal Neoplasms, Stomach Neoplasms

NCT00719550 2013-12-05

AMG 102 Plus ECX for Unresectable Locally Advanced or Metastatic Gastric or Esophagogastric Junction Cancer

Phase 1/2 Completed

Gastrointestinal

Esophageal Neoplasms, Neoplasm Metastasis, Stomach Neoplasms